Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study
Using mixed methods and a new Responses to Challenging Psychedelic Experiences Inventory (ReCiPE), the study identified three response strategies—Acceptance and Reappraisal; Sensory Regulation and Physical Interaction; and Social Support and Disclosure. Acceptance and Reappraisal and Social Support were positively associated with emotional breakthrough, whereas fear-related challenges were linked to lower breakthrough and fewer adaptive coping strategies.
Abstract
Psychedelic substances are garnering renewed interest for their potential therapeutic applications, yet the mechanisms by which challenging experiences during psychedelic use contribute to positive outcomes remains poorly understood. Here we present a mixed-methods investigation into the strategies individuals employ to navigate difficult psychedelic experiences and their relationship to emotional breakthrough. Qualitative analysis of accounts from psilocybin retreat participants (n = 16) informed the development of the Responses to Challenging Psychedelic Experiences Inventory (ReCiPE). In a subsequent online survey (n = 529), exploratory factor analysis of the ReCiPE revealed three primary response strategies: Acceptance and Reappraisal, Sensory Regulation and Physical Interaction, and Social Support and Disclosure. Exploratory correlation and multiple regression analyses demonstrated significant relationships between different types of challenges, response strategies and emotional breakthrough. Notably, Acceptance and Reappraisal, and Social Support and Disclosure strategies were positively associated with greater emotional breakthrough. Fear-related challenges were negatively associated with emotional breakthrough and involved fewer adaptive coping strategies. These findings elucidate the complex interplay between challenging experiences and adaptive responses in psychedelic contexts, offering insights for optimising therapeutic protocols and enhancing safety in both clinical and non-clinical settings.
Research Summary of 'Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study'
Introduction
Psychedelic compounds are under renewed scientific scrutiny for potential therapeutic benefit, yet the role of challenging or difficult experiences within psychedelic sessions remains incompletely understood. Earlier research has emphasised the importance of peak or mystical experiences for therapeutic gains, but there is growing recognition that non-peak elements—such as intense negative emotions, physical discomfort, or confronting past trauma—can also contribute to positive outcomes in some cases, while sometimes producing prolonged difficulties. Contemporary treatment protocols and user guidelines commonly advocate acceptance and 'surrender' during difficult moments, yet the empirical basis for which coping strategies best resolve challenging psychedelic experiences is limited. Wood and colleagues sought to fill this gap using a mixed-methods design. They first used qualitative analysis of retreat participants' written accounts to identify coping strategies and inform the creation of a new measure, the Responses to Challenging Psychedelic Experiences Inventory (ReCiPE). They then administered the ReCiPE in a large online sample to explore its factor structure and to examine associations among types of challenging experiences (measured by the Challenging Experience Questionnaire, CEQ), response strategies (ReCiPE factors), and emotional breakthrough (measured by the Emotional Breakthrough Inventory, EBI). The aim was to characterise common strategies, test whether 'acceptance' strategies predict emotional breakthrough, and explore whether different challenge types call for different responses.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topic
- Author
- APA Citation
Wood, M. J., McAlpine, R. G., & Kamboj, S. K. (2024). Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-79931-w
References (44)
Papers cited by this study that are also in Blossom
Johnson, M. W., Griffiths, R. R., Hendricks, P. S. et al. · Neuropharmacology (2018)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)
Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S. et al. · Journal of Psychopharmacology (2016)
Breeksema, J. J., Niemeijer, A. R., Krediet, E. et al. · CNS Drugs (2020)
Evans, J., Robinson, O., Ketzitzidou-Argyri, E. et al. · PLOS ONE (2023)
Argyri, E. K., Evans, J., Luke, D. et al. · SSRN (2024)
Van Elk, M., Fried, E. I. · Therapeutic Advances in Psychopharmacology (2023)
Romeo, B., Hermand, M., Pétillion, A. et al. · Journal of Psychiatric Research (2021)
Aday, J. S., Davis, A. K., Mitzkovitz, C. M. et al. · ACS Pharmacology and Translational Science (2021)
Show all 44 referencesShow fewer
Zamberlan, F., Sanz, C., Pallavicini, C. et al. · Frontiers in Integrative Neuroscience (2018)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Knight, G., Rucker, J., Cleare, A. J. et al. · Frontiers in Psychiatry (2022)
Kangaslampi, S. · Journal of Psychedelic Studies (2023)
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S. et al. · Journal of Psychopharmacology (2016)
Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)
Roseman, L., Haijen, E. C. H. M., Idialu-Ikato, K. et al. · Journal of Psychopharmacology (2019)
Peill, J. M., Trinci, K. E., Kettner, H. et al. · Journal of Psychopharmacology (2022)
Golden, T. L., Magsamen, S., Sandu, C. C. et al. · Current Topics in Behavioral Neurosciences (2022)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Belser, A. B., Agin-Liebes, G. I., Swift, T. C. et al. · Journal of Humanistic Psychology (2017)
Johnstad, P. G. · Journal of Psychedelic Studies (2021)
Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)
Low, F., Earleywine, M. · Journal of Psychoactive Drugs (2023)
Simonsson, O., Hendricks, P. S., Chambers, R. et al. · Journal of Affective Disorders (2023)
Robinson, O., Evans, J., Luke, D. et al. · Frontiers in Psychology (2024)
Lutkajtis, A., Evans, J. · Journal of Psychedelic Studies (2023)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Hartogsohn, I. · Drug Science Policy and Law (2017)
Murphy, R., Murphy-Beiner, A., Kettner, H. et al. · Frontiers in Pharmacology (2022)
Cavarra, M., Falzone, A., Ramaekers, J. G. et al. · Frontiers in Psychology (2022)
Moreton, S. G., Szalla, L., Menzies, R. E. et al. · Psychopharmacology (2019)
Millière, R. · Frontiers in Human Neuroscience (2017)
Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)
Russ, S. L., Carhart-Harris, R. L., Maruyama, G. et al. · Psychopharmacology (2019)
Deane, G. · Philosophy and the Mind Sciences (2020)
Luoma, J. B., Sabucedo, P., Eriksson, J. et al. · Journal of Contextual Behavioral Science (2019)
Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)
Watts, R., Luoma, J. B. · Journal of Contextual Behavioral Science (2020)
Payne, J. E., Chambers, R., Liknaitzky, P. · ACS Pharmacology and Translational Science (2021)
Radakovic, C., Radakovic, R., Peryer, G. et al. · Journal of Psychedelic Studies (2022)
Kamilar-Britt, P., Gordis, E. B., Earleywine, M. · Psychedelic Medicine (2023)
Levin, A. W., Lancelotta, R., Sepeda, N. D. et al. · PLOS ONE (2024)
Cited By (2)
Papers in Blossom that reference this study
O’Mahony, B., Harrington, C., Harkin, A. et al. · Journal of Psychopharmacology (2026)
Cherniak, A. D., Granqvist, P., Mikulincer, M. et al. · Journal of Psychoactive Drugs (2026)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.